A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

NCT06529419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

537

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: AZD8630
DRUG: Placebo
DEVICE: Inhaler

Sponsor

AstraZeneca